The gene expression comparison according to the COVID-19 disease status showed that the normalized VDR, DEFA1–3 and CCL20 expression is significantly higher in the negative group than in the positive group (Figure 1, P<0.05). This evidence concerns the gene CCL20 and COVID-19.